Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry
Diego López‐Otero, Javier López‐País, Carla Eugenia Cacho Antonio, Pablo Antúnez‐Muiños, Teba González-Ferrero, Marta Pérez-Poza, Óscar Otero García, Brais Díaz‐Fernández, María Bastos-Fernández, Noelia Bouzas‐Cruz, Xoan Carlos Sanmartín-Pena, Alfonso Varela‐Román, Manuel Portela‐Romero, Luís Valdés, Antonio Pose‐Reino, José Ramón González‐Juanatey
Topics & Concepts
Angiotensin Receptor BlockersCoronavirus disease 2019 (COVID-19)Angiotensin-converting enzymeMedicinePharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Angiotensin IIAngiotensin-converting enzyme 2ReceptorInternal medicineVirologyDiseaseInfectious disease (medical specialty)Blood pressureCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Renin-Angiotensin System Studies